These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26392082)

  • 1. Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer.
    Mehmeti M; Allaoui R; Bergenfelz C; Saal LH; Ethier SP; Johansson ME; Jirström K; Leandersson K
    Breast Cancer Res; 2015 Sep; 17(1):130. PubMed ID: 26392082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
    Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapy.
    Wang HY; Park S; Kim S; Ahn S; Lee D; Kim S; Jung D; Park KH; Lee H
    Int J Clin Exp Pathol; 2014; 7(9):5792-800. PubMed ID: 25337220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
    Schroth W; Winter S; Büttner F; Goletz S; Faißt S; Brinkmann F; Saladores P; Heidemann E; Ott G; Gerteis A; Alscher MD; Dippon J; Schwab M; Brauch H; Fritz P
    Breast Cancer Res Treat; 2016 Jan; 155(1):85-97. PubMed ID: 26650824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
    Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
    Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival.
    Bergenfelz C; Gaber A; Allaoui R; Mehmeti M; Jirström K; Leanderson T; Leandersson K
    Br J Cancer; 2015 Oct; 113(8):1234-43. PubMed ID: 26448179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
    Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
    Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells.
    Uno K; Kato K; Atsumi T; Suzuki T; Yoshitake J; Morita H; Ohara S; Kotake Y; Shimosegawa T; Yoshimura T
    Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G1004-12. PubMed ID: 17855767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.
    Saji S; Omoto Y; Shimizu C; Warner M; Hayashi Y; Horiguchi S; Watanabe T; Hayashi S; Gustafsson JA; Toi M
    Cancer Res; 2002 Sep; 62(17):4849-53. PubMed ID: 12208729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
    Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M
    Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells.
    Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X
    Vet Res; 2008; 39(2):11. PubMed ID: 18096120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone administration modulates TLRs/NF-kappaB signaling pathway in rat brain after cortical contusion.
    Chen G; Shi J; Jin W; Wang L; Xie W; Sun J; Hang C
    Ann Clin Lab Sci; 2008; 38(1):65-74. PubMed ID: 18316784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.
    Biswas DK; Iglehart JD
    J Cell Physiol; 2006 Dec; 209(3):645-52. PubMed ID: 17001676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dependence on p38 MAPK signalling in the up-regulation of TLR2, TLR4 and TLR9 gene expression in Trichomonas vaginalis-treated HeLa cells.
    Chang JH; Park JY; Kim SK
    Immunology; 2006 Jun; 118(2):164-70. PubMed ID: 16771851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.
    Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM
    Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hymenolepis diminuta: analysis of the expression of Toll-like receptor genes (TLR2 and TLR4) in the small and large intestines of rats. Part II.
    Kosik-Bogacka DI; Wojtkowiak-Giera A; Kolasa A; Czernomysy-Furowicz D; Lanocha N; Wandurska-Nowak E; Salamatin R; Jagodzinski PP
    Exp Parasitol; 2013 Oct; 135(2):437-45. PubMed ID: 23994484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.
    Wiebe JP; Zhang G; Welch I; Cadieux-Pitre HA
    Breast Cancer Res; 2013 May; 15(3):R38. PubMed ID: 25927181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.